Skip to main content

How Much Calcium Is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration

HSS Journal volume 2, pages 130–135 (2006)Cite this article

Abstract

Introduction

Different forms of water vary in calcium content. High divalent ion (i.e., Ca2+, Mg2+, etc.) concentration is deleterious to the absorption and efficacy of the bisphosphonate group of drugs in osteoporosis treatment. Water with high calcium concentration may also present an alternate pathway of calcium administration. In either case, knowing the actual concentration is critical.

Hypothesis

The current paper is a surveillance study. We hypothesize that there is considerable variation in the calcium concentrations in the various water sources: tap water from US and Canadian cities of different regions and purified, spring, and mineral bottled waters. In addition, we hypothesize that the water filter removes a significant amount of minerals including calcium from the water.

Methodology

Calcium concentrations in various city tap waters, as well as an assorted number of bottled waters, were determined through the direct inspection of scientific data. The effect of filtering was also determined by mineral analysis of mineral water directly before and after filtration.

Result

The calcium concentration of water varies from 1 to 135 mg/L across the USA and Canada. Most spring waters were found to have a relatively low calcium concentration, with an average of 21.8 mg/L. Purified waters contain a negligible calcium concentration. Mineral waters, on the other hand, were generally found to contain higher calcium concentrations, an average of 208 mg/L of calcium. Filtration was found to remove a considerable amount of calcium from the water, removing 89% on average.

Conclusion

Calcium concentration in water varied substantially from different sources in the USA and Canada. Bottled waters presented with concentrations of calcium covering a very large range. Certain tap and bottled waters present with concentrations of calcium sufficient to exhibit a deleterious effect on bisphosphonate treatment. Alternatively, certain waters may be used as a source of calcium that may provide over 40% of the recommended daily intake for calcium.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Reid IR, Ames RW, Evans MC et al (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J 328:460–464

    Article  CAS  Google Scholar 

  2. Shea B, Wells G, Cranney A et al (2002) Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23:552–559

    Article  PubMed  CAS  Google Scholar 

  3. National Institutes of Health (1994) Optimal calcium intake. NIH Consens Statement 12:1–31

    Google Scholar 

  4. Dawson-Hughes B (1998) Vitamin D and calcium: recommended intake for bone health. Osteoporos Int 8:S30–S34

    PubMed  CAS  Google Scholar 

  5. Nordin BEC (2000) Calcium requirement is a sliding scale. Am J Clin Nutr 71:1381–1383

    PubMed  CAS  Google Scholar 

  6. Dawson-Hughes B, Harris S, Krall S et al (1997) Effect of calcium and vitamin-D supplementation on bone density in men and women 65 years or age or older. N Engl J Med 337:670–676

    Article  PubMed  CAS  Google Scholar 

  7. Wu DD, Boyd RD, Fix TJ et al (1990) Regional patterns of bone loss and altered bone remodeling in response to calcium deprivation in laboratory rabbits. Calcif Tissue Int 47:18–23

    PubMed  Article  CAS  Google Scholar 

  8. Espallargues M, Sampietro-Colom L, Estrada MD et al (2001) Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 12:811–822

    Article  PubMed  CAS  Google Scholar 

  9. National Institutes of Health (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17:1–45

    Google Scholar 

  10. Valtin H (2002) “Drink at least eight glasses of water a day.” Really? Is there scientific evidence for “8 × 8”?. Am J Physiol Regul Integr Comp Physiol 283:R993–R1004

    PubMed  Google Scholar 

  11. Böhmer H, Müller H, Resch KL (2000) Calcium supplementation with calcium-rich mineral waters: a systematic review and meta-analysis of its bioavailability. Osteoporos Int 11:938–943

    Article  PubMed  Google Scholar 

  12. Janner M, Muhlbauer RC, Fleisch H (1991) Sodium EDTA enhances intestinal absorption of two bisphosphonates. Calcif Tissue Int 49:280–283

    PubMed  Article  CAS  Google Scholar 

  13. Hosking D, Chilvers CED, Christiansen C et al (1998) Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 228:485–492

    Article  Google Scholar 

  14. Lieberman UA, Weiss SR, Bröll J et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437–1443

    Article  PubMed  Google Scholar 

  15. Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610

    Article  PubMed  CAS  Google Scholar 

  16. Saag KG, Emkey R, Schnitzer T et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292–299

    Article  PubMed  CAS  Google Scholar 

  17. Devogelaer JP, Broll H, Correa-Potter R et al (1996) Oral alendronate induced progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141–150

    Article  PubMed  CAS  Google Scholar 

  18. Black DM, Cummings SR, Karpf DB et al (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541

    PubMed  Article  CAS  Google Scholar 

  19. Lin JH (1996) Bisphosphonates: review of their pharmacokinetic properties. Bone 18:75–85

    Article  PubMed  CAS  Google Scholar 

  20. Rodan GA, Seedor JG, Balena R (1993) Preclinical pharmacology of alendronate. Osteoporos Int 3:S7–S12

    Article  PubMed  Google Scholar 

  21. Dunn CJ, Goa KL (2001) Risedronate, a review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 61:685–712

    Article  PubMed  CAS  Google Scholar 

  22. Porras AG, Holland SD, Gertz BJ (1999) Pharmacokinetics of alendronate. Clin Pharmacokinet 36:315–328

    Article  PubMed  CAS  Google Scholar 

  23. Laitinen K, Patronen A, Harju P et al (2000) Timing of food intake has a marked effect on the bioavailability of clodronate. Bone 27:293–296

    Article  PubMed  CAS  Google Scholar 

  24. Merck and Co. Fosamax® Alendronate Sodium (Prescribing Information). Downloaded from Fosamax.com on July 7, 2003

  25. P&G Pharmaceuticals. Actonel® Risendronate Sodium (Prescribing Information) Downloaded from Actonel.com on July 7, 2003

  26. Brown TL, LeMay HE, Bursten BE et al (2003) Chemistry: The Central Science Ninth edition Upper Saddle River, New Jersey Prentice Hall, p. 684

    Google Scholar 

  27. Sheikh MS, Santa Ana CA, Nicar MJ et al (1987) Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 317:532–536

    PubMed  CAS  Article  Google Scholar 

  28. Heaney RP, Dowell MS, Barger-Lux MJ (1999) Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporos Int 9:19–23

    Article  PubMed  CAS  Google Scholar 

  29. Rozen GS, Rennert G, Dodiuk-Gad RP et al (2003) Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. Am J Clin Nutr 78:993–998

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital for Special Surgery, New York, NY, USA

    Simon Morr & Joseph M. Lane MD

  2. Jackson Memorial Hospital, Miami, FL, USA

    Esteban Cuartas MD

  3. NYU Medical Center, New York, NY, USA

    Basil Alwattar MD

Authors
  1. Simon Morr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esteban Cuartas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Basil Alwattar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph M. Lane MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph M. Lane MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Morr, S., Cuartas, E., Alwattar, B. et al. How Much Calcium Is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration. HSS Jrnl 2, 130–135 (2006). https://doi.org/10.1007/s11420-006-9000-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11420-006-9000-9

Key words

  • bioavailability
  • bisphosphonate
  • calcium supplements
  • filter
  • water